Non-occlusive Mesenteric Ischemia as a Fatal Complication in Acute Pancreatitis: A Case Series

2019 ◽  
Vol 65 (4) ◽  
pp. 1212-1222 ◽  
Author(s):  
Cynthia Reichling ◽  
Leda Nobile ◽  
Martina Pezzullo ◽  
Julie Navez ◽  
Najla Bachir ◽  
...  
2020 ◽  
Vol 65 (5) ◽  
pp. 1553-1555
Author(s):  
Maria Antonietta Mazzei ◽  
Susanna Guerrini ◽  
Francesco Gentili ◽  
Ilaria Monteleone ◽  
Gabriele Lucii ◽  
...  

Pancreatology ◽  
2003 ◽  
Vol 3 (4) ◽  
pp. 316-322 ◽  
Author(s):  
Masahiko Hirota ◽  
Kotaro Inoue ◽  
Yu Kimura ◽  
Takao Mizumoto ◽  
Kinumo Kuwata ◽  
...  

2021 ◽  
Vol 13 (1) ◽  
pp. 98-103
Author(s):  
Agnieszka Pawłowska-Kamieniak ◽  
Paulina Krawiec ◽  
Elżbieta Pac-Kożuchowska

Acute pancreatitis (AP) appears to be rare disease in childhood. In children, it has a different aetiology and course, and requires different management than in adult patients. The diagnosis of AP is based on at least two of the three criteria, which include typical clinical symptoms, abnormalities in laboratory tests and/or imaging studies of the pancreas. There are many known causes leading to AP in children including infections, blunt abdominal trauma, genetic factors, gallstone disease, metabolic disorders, anatomical defects of the pancreas, systemic diseases, as well as drugs, including antiepileptic drugs, and especially preparations of valproic acid. In our study, we present four cases of young patients diagnosed with acute pancreatitis as a complication of valproic acid therapy and we present a review of the literature. We believe that the activity of pancreatic enzymes should be monitored in children treated with valproate preparations in the case of clinical symptoms suggesting AP.


Dose-Response ◽  
2020 ◽  
Vol 18 (1) ◽  
pp. 155932582090235
Author(s):  
Shih-Wei Lai ◽  
Cheng-Chan Yu ◽  
Cheng-Li Lin ◽  
Kuan-Fu Liao

Background/Objective: Some case series and case report have shown the association between the risk of acute pancreatitis and use of selective serotonin reuptake inhibitors. The results of systematic studies were not consistent. Methods: A meta-analysis was performed to investigate the risk of acute pancreatitis associated with use of selective serotonin reuptake inhibitors. Results: There was no statistical association between the risk of acute pancreatitis and selective serotonin reuptake inhibitors use (odds ratio: 1.19, 95% confidence interval: 0.93-1.51). Conclusions: Despite reaching no statistical significance, the possibility of the association between the risk of acute pancreatitis and selective serotonin reuptake inhibitors use cannot be totally excluded.


2010 ◽  
Vol 6 (1) ◽  
pp. 112 ◽  
Author(s):  
SajidQ Qureshi ◽  
RakeshS Neve ◽  
SudipA Raina ◽  
RajeshC Mistry

Sign in / Sign up

Export Citation Format

Share Document